MODD Valuation

Modular Medical Inc

Add to Watchlist

Advanced Chart

0.720

+0.02(2.857%)1D

Overview
Forecast
Valuation
Earnings

MODD Relative Valuation

MODD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MODD is overvalued; if below, it's undervalued.

Historical Valuation

Modular Medical Inc (MODD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 12.09 is considered Undervalued compared with the five-year average of -2.92. The fair price of Modular Medical Inc (MODD) is between 0.74 to 3.55 according to relative valuation methord. Compared to the current price of 0.70 USD , Modular Medical Inc is Undervalued By 5.62%.

Relative Value

Fair Zone

0.74-3.55

Current Price：0.70

5.62%

Undervalued

-1.80

Trailing

Forward

0.00

EV/EBITDA

Modular Medical Inc. (MODD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-2.82

EV/EBIT

Modular Medical Inc. (MODD) has a current EV/EBIT of -2.82. The 5-year average EV/EBIT is -3.24. The thresholds are as follows: Strongly Undervalued below -6.96, Undervalued between -6.96 and -5.10, Fairly Valued between -1.38 and -5.10, Overvalued between -1.38 and 0.48, and Strongly Overvalued above 0.48. The current Forward EV/EBIT of -2.82 falls within the Historic Trend Line -Fairly Valued range.

12.26

Modular Medical Inc. (MODD) has a current PS of 12.26. The 5-year average PS is 318.46. The thresholds are as follows: Strongly Undervalued below -608.97, Undervalued between -608.97 and -145.26, Fairly Valued between 782.17 and -145.26, Overvalued between 782.17 and 1245.89, and Strongly Overvalued above 1245.89. The current Forward PS of 12.26 falls within the Historic Trend Line -Fairly Valued range.

-4.15

P/OCF

Modular Medical Inc. (MODD) has a current P/OCF of -4.15. The 5-year average P/OCF is -2.57. The thresholds are as follows: Strongly Undervalued below -6.92, Undervalued between -6.92 and -4.75, Fairly Valued between -0.39 and -4.75, Overvalued between -0.39 and 1.78, and Strongly Overvalued above 1.78. The current Forward P/OCF of -4.15 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Modular Medical Inc. (MODD) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Modular Medical Inc (MODD) has a current Price-to-Book (P/B) ratio of 3.31. Compared to its 3-year average P/B ratio of 4.76 , the current P/B ratio is approximately -30.40% higher. Relative to its 5-year average P/B ratio of -2751.39, the current P/B ratio is about -100.12% higher. Modular Medical Inc (MODD) has a Forward Free Cash Flow (FCF) yield of approximately -52.02%. Compared to its 3-year average FCF yield of -41.88%, the current FCF yield is approximately 24.21% lower. Relative to its 5-year average FCF yield of -32.61% , the current FCF yield is about 59.53% lower.

3.27

P/B

Median3y

4.76

Median5y

-2751.39

-51.33

FCF Yield

Median3y

-41.88

Median5y

-32.61

Competitors Valuation Multiple

The average P/S ratio for MODD's competitors is 3.15, providing a benchmark for relative valuation. Modular Medical Inc Corp (MODD) exhibits a P/S ratio of 12.26, which is 288.61% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Vicarious Surgical Inc

Loss

40.12M

NMTC.O

NeuroOne Medical Technologies Corp

Firefly Neuroscience Inc

X T L Biopharmaceuticals Ltd

0.03

1.04B

Performance Decomposition

Market capitalization of MODD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of MODD in the past 1 year is driven by Unknown.